Starting Dose 0.25 mg (250 mcg) Low loading dose used in practice
A patient who is obese and diabetic may ultimately receive a different therapy than someone who is obese and hypertensive, or obese with rheumatoid arthritis, or obese with cognitive decline if we can design drugs that are turbo-charged to address these additional pharmacologies. Rounding up his presentation, DiMarchi encouraged the industry to also embrace observation
According to the medicine's information leaflet, patients might experience headaches, dizziness, nausea, or a general feeling of being unwell
How Products in This Category Are Typically Positioned GLP-1 (glucagon-like peptide-1) is a gut hormone produced by intestinal L-cells
After stop of reaction using 50 mM TBS, the samples were counter-stained with hematoxylin solution
It is unstable, photo-sensitive and irritating at high concentrations